Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.50
-0.70 (-2.24%)
May 8, 2026, 12:52 PM CST

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Health Food Products Department
879.09M554.46M492.78M494.24M327.79M
Health Food Products Department Growth
58.55%12.52%-0.30%50.78%66.84%
Western Medicine Section
177.12M135.57M260.55M218.29M113.29M
Western Medicine Section Growth
30.65%-47.97%19.36%92.68%14.06%
Joint
---221.00K-
Total
1.06B690.03M753.33M712.75M441.08M
Total Growth
53.07%-8.40%5.69%61.59%49.12%

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Taiwan
999.59M620.75M619.47M594.93M391.53M
Taiwan Growth
61.03%0.21%4.13%51.95%56.49%
Japan
41.81M55.74M95.62M70.74M35.20M
Japan Growth
-24.99%-41.71%35.16%100.97%-11.45%
Singapore
11.30M8.52M4.49M--
Singapore Growth
32.60%89.86%---
Other Countries
3.51M5.03M33.75M3.88M1.92M
Other Countries Growth
-30.21%-85.11%768.98%101.98%-67.13%
South Korea
---42.97M12.42M
South Korea Growth
---245.95%-
Total
1.06B690.03M753.33M712.53M441.08M
Total Growth
53.07%-8.40%5.73%61.54%49.12%
Source: S&P Global Market Intelligence.